Jessica Nye, PhD

Researchers quantified the performance of diagnostic testing methods for respiratory syncytial virus and assessed the use of multiple specimen types on detection rates.

Researchers evaluated whether there is an association between remdesivir dosing and time to bradycardia among patients hospitalized with COVID-19 infection.

Researchers compared the safety and efficacy of monoclonal antibody treatments for protection against respiratory syncytial virus infection among infants and children.

Researchers studied the trajectories of pulmonary arterial pressure, and the clinical phenotype associated with each trajectory, in patients with systemic sclerosis.

Researchers evaluated access to tuberculosis diagnostics among hospitalized patients with HIV infection before vs during the COVID-19 pandemic.

Researchers evaluated protection conferred by 2- and 3-doses of the COVID-19 BNT162b2 vaccine among adolescents during the Delta and Omicron periods.

Researchers evaluated the demographic, clinical, and laboratory characteristics of patients hospitalized with COVID-19 infection.

Researchers evaluated the effects of remdesivir on mortality risk among patients hospitalized with COVID-19 outside of the clinical trial setting.

Researchers examined the association between pneumococcal carriage and COVID-19 infection.

Researchers evaluated risk factors associated with persistent COVID-19 symptoms 1 year after the acute phase of infection.

Researchers assessed the risk for secondary monkeypox transmission among individuals who were exposed to the first US patient diagnosed with the infection.

Researchers evaluated the effect of influenza vaccination on reducing antibiotic prescription outcomes for adults diagnosed with influenza-like illness.

Researchers evaluated whether finerenone treatment protects against pneumonia and COVID-19 in patients with chronic kidney disease and type 2 diabetes.

Adding tremelimumab and durvalumab to chemotherapy improves progression-free survival and overall survival in patients with metastatic non-small cell lung cancer, phase 3 data suggest.

Researchers evaluated outcomes among patients hospitalized with COVID-19 who received high- vs standard-dose dexamethasone.

Researchers sought to examine characteristics of and outcomes for patients with venothromboembolism and concomitant fibroids or gynecologic cancers.

Researchers established the therapeutic efficacy of topical blockade of substance P in managing patients with red eyes.

A study was conducted to determine 1-year outcomes following TAVR for patients receiving supplemental oxygen at home for treatment of COPD.

Researchers evaluated the efficacy of the SpikoGen® vaccine for protection against symptomatic COVID-19.

Researchers sought to determine if self-reported lung-related comorbidities was an indicator of poor outcomes on lung cancer screening.

First-line cemiplimab can improve long-term survival outcomes, compared with chemotherapy, in advanced non-small cell lung cancer.

Researchers compared the effects of macrolides in combination with either ampicillin or ceftriaxone among patients hospitalized with community-acquired pneumonia.

Researchers evaluated patients with monkeypox to determine the clinical characteristics and complications associated with the disease.

A review of patient records revealed that survivors of some cancers do not undergo routine distress screening, regardless of race, age, ethnicity, and other characteristics.

Investigators assessed the impact of SARS-Cov-2 infection on pressure-pain sensitivity, conditioned pain modulation, and exercise-induced hypoalgesia.

Researchers assessed the reactogenicity of COVID-19 mRNA vaccine boosters coadministered with a seasonal influenza vaccine.

Using postmortem high resolution MRI, researchers characterized the possible mechanisms of neural damage in patients infected with COVID-19.

Researchers sought to evaluate whether immunocompromised individuals infected with COVID-19 are at a higher risk for ICU admission and death compared with nonimmunocompromised individuals.

Researchers assessed temporal and regional trends to estimate the global rate of macrolide-resistant Mycoplasma pneumoniae infections.

Researchers assessed the effects of homologous COVID-19 vaccination among patients who had suboptimal immune responses following receipt of the CVnCOV vaccine.